These are ten of the analyst calls we are focusing on this Wednesday morning in pre-market trading: Bristol-Myers (NYSE: BMY) cut to Neutral at Cowen. Marriott (NYSE: MAR) cut to Perform at…
Today turned out being an ugly day, but there were many stocks that fell sharply to new 52-week lows all on their own without help from the market working against them. Allergan…
Synchronoss Technologies Inc (NASDAQ: SNCR) looks now like it will be one of the worst seen earnings moves of popular companies in all of this earnings season. The outsourced device activation provider…
Synchronoss Technologies, Inc. (NASDAQ: SNCR) has just posted earnings of $0.22 EPS non-GAAP on revenues of $36.4 million. First Call had estimates of $0.20 EPS and $35.65 million in revenues. The company…
Douglas A. McIntyre On Monday, we’ll get to see earnings out of Synchronoss Technologies, Inc. (NASDAQ:SNCR). The estimates from First Call for the transaction management software developer are $0.20 EPS on $35.65 million in revenues. …
Douglas A. McIntyre This morning Goldman Sachs has announced some changes to its CONVICTION BUY LIST: Amdocs (NYSE: DOX) is being added to the Americas Conviction Buy list with a 49% return potential to its…
These are not the only impact analyst calls, but these are the top research calls that 247WallSt.com is focusing on pre-market this Thursday: Buffalo Wild Wings (BWLD) started as Underweight at J.P.Morgan.…
